CCT239065

Overview

CCT239065 is an orally available, effective inhibitor of the mutant protein kinase V600E BRAF ( RAF ) with anti-tumor activity. CCT239065 inhibits downstream signaling of V600E BRAF in cancer cells, blocking DNA synthesis and suppressing proliferation.

Application

Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > DNA/RNA Synthesis | Products > Signaling Pathways > Raf

Product Information

• Catalog No.: HY-14716
• CAS No.: 1163719-51-4
• Molecular Formula: C29H29N7O3S
• Molecular Weight: 555.65
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source